Prucalopride manufacturers

Filters

Filters

Filters , active

Country of origin : India
None products found

prucalopride

Tablets, film coated 1 mg, 2 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Costa Rica
Manufacturer #1338

The company is a prominent player in the generic pharmaceutical industry with strong capabilities in research, development, manufacturing, and commercialization. It has received multiple GMP certifications from international regulatory bodies, such as those from Bavaria, Switzerland, Slovenia, and Mexico, underscoring its commitment to quality and global standards. Recognized for its innovation, the company has earned numerous product patents and prestigious awards, such as the Pharmexcil Patent Award. With ISO certifications for quality and environmental management, a robust infrastructure of five manufacturing facilities in India, and strategic partnerships for producing HIV/AIDS drugs, the company demonstrates a strong focus on expanding its global footprint and delivering affordable healthcare solutions.

prucalopride

Tablets 1 mg, 2 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, FDA
Manufacturer #2655

The company is a pharmaceutical manufacturer engaged in the research, development, production and distribution of a broad portfolio of branded and generic pharmaceutical products across multiple therapeutic areas, operating with state-of-the-art manufacturing facilities and quality systems to produce and supply these pharmaceutical products to healthcare providers and markets in India and internationally.

prucalopride

Tablets 1 mg, 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Unavailable markets
United Kingdom
Manufacturer #32970
This company is a leading manufacturer of pharmaceutical products, specializing in pellets and granules, tablets, capsules, creams, and ointments. They have a strong track record of success, with GMP certifications from the EU, TGA (Australia), ANVISA (Brazil), and other regulatory bodies. Their expertise extends to multiple therapy areas, leveraging their manufacturing capabilities across various dosage forms. The company caters to a global market, exporting to over 47 countries across regions including North America, South America, Asia, and Europe. They are recognized for their commitment to quality, innovation, and technological advancements in manufacturing processes.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.